ARCHIVES

BCDDP “Major Accomplishment” Described By ACS’ Holleb

This article is from The Cancer Letter archive.

Vol. 04 No. 29 | July 21, 1978

Download PDF Visit The Full Archive

Related Articles

FDA Rile Changes Reporting Requirements for Adverse Events

November 18, 1994

How NCI Would Apportion New Round Of budget Cuts- 1980 $17 Million, 1981 $42.7 Million

April 11, 1980

Monitoring of Clinical Trials Finds Two Major Problems; Investigators Are Suspended

August 19, 1983

Becker, Brown Testify On Biomedical Funding, Manpower Needs

March 23, 1990

In Brief: Columbia University Double Lab Space; GM Cancer Awards to Suit, Folkman, Nurse

June 6, 1997

Eleven Chemicals Rated for Tests

September 1, 1978